Friday, 7 February 2014 - 10:25

500 activists from the Treatment Action Campaign (TAC) picketed yesterday at the offices of the pharmaceutical company Merck, Sharp and Dohme (MSD) over their involvement in the controversial PharmaGate plot. The plot aimed to undermine and substantially delay South Africa’s long awaited IP policy – a policy that outlines several critical reforms to South Africa’s existing patent legislation. These reforms are essential to ensuring continued and improved access to essential medicines for all who live in South Africa.

Why is the PharmaGate plot unacceptable?

Read more
Wednesday, 5 February 2014 - 17:16

Today the Treatment Action Campaign (TAC), SECTION27 and Doctors without Borders (MSF) held a public action outside an Executive Board meeting of the Innovative Pharmaceutical Association South Africa (IPASA).
There has been significant public outrage about a proposal exposed by the Mail & Guardian on 16 January 2014, outlining a R6million deceptive plot to undermine and delay South Africa’s IP Policy reform process. Through incorporating legal safeguards into the existing patent system, these moderate reforms will increase access to affordable life-saving medicines in...

Read more
Tuesday, 21 January 2014 - 12:40

CAPE TOWN, 21st January: A leaked industry email published by Knowledge Ecology International (KEI) yesterday proves the direct involvement of multinational pharmaceutical companies and the Innovative Pharmaceuticals Association of South Africa (IPASA) in the PharmaGate scandal. Despite attempting to distance themselves from the plot in public statements since the Mail & Guardian broke the story on Friday 17 January 2014, the leaked email illustrates that both IPASA and US-based industry body PhRMA (the Pharmaceutical Researchers and Manufacturers of America) actively selected the “...

Read more
Friday, 17 January 2014 - 10:46

Today the Mail & Guardian published a story entitled - "Motsoaledi: Big pharma's 'satanic' plot is genocide" regarding leaked documents revealing that the international pharmaceutical industry planned a $450,000 campaign against the proposed patent law reforms in South Africa. In reaction the Treatment Action Campaign's General Secretary Vuyiseka Dubula made the following statement:

"The Treatment Action Campaign is outraged over what appears to be a covert and well-funded plan...

Read more
Wednesday, 18 December 2013 - 14:47

18 December 2013
In recent months the Treatment Action Campaign (TAC) has campaigned to draw attention to serious problems in the public health system that are having a negative impact on the quality of HIV prevention and treatment programmes. During our National Day of Action on September 12th this year we delivered memoranda to provincial governments in six provinces outlining these challenges. On November 28th the Stop Stockouts Project, of which TAC is a partner, published a report into stock-outs of HIV and tuberculosis medicines at facilities across the country. In this...

Read more